Noted for its ‘knowledge of the market’, ‘flexibility in negotiation and innovation in solutions’, ’SPLaw combines IP, life sciences, and technology expertise to advise multinational and Brazilian life sciences companies on an array of legal matters. Typical mandates for the firm include advising on transactions, regulatory issues, disputes, IP mandates, and clinical trials. Benny Spiewak is highly regarded for his experience in IP matters; he has regularly assists clients from the pharma, medical devices, biotech, and other life sciences segments with patents issues, such as post-grant oppositions, and appeals before the public trade mark office. The recent addition of Guillermo Glassman, who previously worked in-house at EMS Pharmaceuticals, has bolstered the team’s litigation capabilities. Senior associate Daniela Jambor is a specialist in Brazilian regulation of genetically modified organisms and medical cannabis.
Testimonials
Collated independently by Legal 500 research team.
‘SPLaw is an firm specialised in the area of healthcare and life sciences with differentiated quality and performance in the legal market. It performs excellently and always handles work with a technical basis, providing insights beyond what is expected. Another important point to highlight is its technical competence and sense of priority. They are at the forefront of discussions in this market.’
‘Benny Spiewak has excellent knowledge and a highly differentiated performance in healthcare and life sciences. He is a pioneer in the market.’
Key clients
- AstraZeneca / Alexion
- Boehringer Ingelheim
Work highlights
- Advising Organon on the $65m manufacturing, co-marketing, distribution, and license agreement entered with Finland-based Orion Pharmaceuticals, which secured Organon rights for Sandrena.
- Advising Teva’s Active Pharmaceutical Ingredients Industry (TAPI) unit on the intellectual property system for active pharmaceutical ingredients.